30 years of historical data (1996–2025) · Real Estate · REIT - Healthcare Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Omega Healthcare Investors, Inc. trades at 23.0x earnings, roughly in line with its 5-year average of 22.1x, sitting at the 54th percentile of its historical range. This is roughly in line with the Real Estate sector median P/E of 24.1x. On a free-cash-flow basis, the stock trades at 15.1x P/FCF, 14% above the 5-year average of 13.3x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $13.3B | $13.8B | $10.2B | $7.7B | $6.8B | $7.2B | $8.5B | $9.4B | $7.4B | $5.7B | $6.3B |
| Enterprise Value | $17.5B | $18.0B | $14.6B | $12.3B | $11.8B | $12.5B | $13.5B | $14.5B | $11.9B | $10.2B | $10.6B |
| P/E Ratio → | 22.95 | 22.86 | 24.42 | 30.66 | 15.53 | 16.91 | 53.41 | 27.50 | 26.23 | 54.00 | 16.45 |
| P/S Ratio | 11.07 | 11.50 | 9.74 | 8.09 | 7.77 | 6.80 | 9.57 | 10.13 | 8.36 | 6.27 | 7.00 |
| P/B Ratio | 2.54 | 2.53 | 2.16 | 2.04 | 1.80 | 1.76 | 2.12 | 2.17 | 1.96 | 1.46 | 1.50 |
| P/FCF | 15.09 | 15.68 | 14.36 | 13.05 | 11.80 | 11.53 | 13.49 | 22.72 | 20.48 | 11.59 | 11.32 |
| P/OCF | 15.09 | 15.68 | 13.66 | 12.26 | 10.91 | 10.01 | 12.06 | 16.99 | 14.76 | 9.85 | 10.07 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Omega Healthcare Investors, Inc.'s enterprise value stands at 16.3x EBITDA, 6% above its 5-year average of 15.4x. This is roughly in line with the Real Estate sector median of 17.0x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 15.03 | 13.85 | 12.95 | 13.46 | 11.73 | 15.18 | 15.63 | 13.50 | 11.21 | 11.74 |
| EV / EBITDA | 16.27 | 16.75 | 15.10 | 15.21 | 16.31 | 13.72 | 17.32 | 17.01 | 15.28 | 16.89 | 12.79 |
| EV / EBIT | 23.34 | 21.31 | 22.66 | 25.05 | 17.65 | 19.15 | 35.12 | 26.28 | 23.90 | 31.22 | 18.89 |
| EV / FCF | — | 20.49 | 20.43 | 20.91 | 20.43 | 19.87 | 21.39 | 35.06 | 33.07 | 20.73 | 18.99 |
Margins and return-on-capital ratios measuring operating efficiency
Omega Healthcare Investors, Inc. earns an operating margin of 62.6%, significantly above the Real Estate sector average of 24.8%. Operating margins have expanded from 51.5% to 62.6% over the past 3 years, signaling improving operational efficiency. ROE of 11.6% is modest. ROIC of 6.0% represents adequate returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.5% | 44.5% | 98.6% | 98.4% | 98.2% | 98.8% | 98.6% | 98.4% | 100.0% | 100.0% | 100.0% |
| Operating Margin | 62.6% | 62.6% | 62.7% | 51.5% | 44.7% | 53.3% | 50.7% | 59.4% | 56.4% | 34.7% | 62.2% |
| Net Profit Margin | 49.3% | 49.3% | 38.6% | 25.5% | 48.6% | 39.2% | 17.9% | 36.7% | 31.9% | 11.1% | 40.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.6% | 11.6% | 9.6% | 6.4% | 10.8% | 10.2% | 3.8% | 8.4% | 7.4% | 2.5% | 8.8% |
| ROA | 5.9% | 5.9% | 4.3% | 2.6% | 4.5% | 4.4% | 1.7% | 3.7% | 3.2% | 1.1% | 4.3% |
| ROIC | 6.0% | 6.0% | 5.7% | 4.3% | 3.2% | 4.6% | 3.7% | 4.7% | 4.5% | 2.8% | 5.2% |
| ROCE | 7.9% | 7.9% | 7.2% | 5.5% | 4.3% | 6.1% | 4.9% | 6.4% | 6.1% | 3.8% | 7.1% |
Solvency and debt-coverage ratios — lower is generally safer
Omega Healthcare Investors, Inc. carries a Debt/EBITDA ratio of 4.0x, which is moderately leveraged (50% below the sector average of 7.9x). Net debt stands at $4.2B ($4.3B total debt minus $27M cash). Interest coverage of 3.8x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.78 | 0.78 | 1.02 | 1.35 | 1.39 | 1.28 | 1.28 | 1.18 | 1.21 | 1.18 | 1.04 |
| Debt / EBITDA | 3.96 | 3.96 | 5.02 | 6.27 | 7.30 | 5.78 | 6.61 | 6.02 | 5.83 | 7.59 | 5.28 |
| Net Debt / Equity | — | 0.78 | 0.91 | 1.23 | 1.31 | 1.27 | 1.24 | 1.18 | 1.20 | 1.15 | 1.01 |
| Net Debt / EBITDA | 3.94 | 3.94 | 4.48 | 5.72 | 6.89 | 5.76 | 6.40 | 5.99 | 5.82 | 7.44 | 5.17 |
| Debt / FCF | — | 4.81 | 6.06 | 7.86 | 8.63 | 8.35 | 7.91 | 12.35 | 12.59 | 9.13 | 7.67 |
| Interest Coverage | 3.83 | 3.83 | 2.90 | 2.09 | 2.87 | 2.77 | 1.73 | 2.65 | 2.47 | 1.48 | 3.19 |
Short-term solvency ratios and asset-utilisation metrics
Omega Healthcare Investors, Inc.'s current ratio of 3.46x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has declined from 7.25x to 3.46x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.46 | 3.46 | 8.03 | 7.25 | 5.30 | 6.53 | 3.64 | 2.82 | 2.06 | 2.56 | 2.98 |
| Quick Ratio | 3.46 | 3.46 | 8.03 | 7.25 | 5.30 | 6.53 | 3.64 | 2.82 | 2.06 | 2.56 | 2.98 |
| Cash Ratio | 0.05 | 0.05 | 1.58 | 1.44 | 0.89 | 0.07 | 0.43 | 0.06 | 0.02 | 0.15 | 0.17 |
| Asset Turnover | — | 0.12 | 0.11 | 0.10 | 0.09 | 0.11 | 0.09 | 0.09 | 0.10 | 0.10 | 0.10 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Omega Healthcare Investors, Inc. returns 5.6% to shareholders annually primarily through dividends. The payout ratio exceeds 100% at 132.2%, meaning the company is paying out more than it earns — this level is unsustainable long-term without earnings recovery. The earnings yield of 4.4% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 5.6% | 5.7% | 6.7% | 8.4% | 9.3% | 8.8% | 7.2% | 6.0% | 7.2% | 8.8% | 7.2% |
| Payout Ratio | 132.2% | 132.2% | 168.7% | 265.9% | 148.2% | 153.0% | 384.3% | 165.4% | 187.8% | 500.5% | 123.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.4% | 4.4% | 4.1% | 3.3% | 6.4% | 5.9% | 1.9% | 3.6% | 3.8% | 1.9% | 6.1% |
| FCF Yield | 6.6% | 6.4% | 7.0% | 7.7% | 8.5% | 8.7% | 7.4% | 4.4% | 4.9% | 8.6% | 8.8% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 2.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 5.6% | 5.7% | 6.7% | 8.4% | 11.4% | 8.8% | 7.2% | 6.0% | 7.2% | 8.8% | 7.2% |
| Shares Outstanding | — | $311M | $270M | $250M | $244M | $244M | $235M | $222M | $210M | $207M | $202M |
Compare OHI with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $13B | 23.0 | 16.3 | 15.1 | 44.5% | 62.6% | 11.6% | 6.0% | 4.0 | |
| $5B | 28.3 | 15.6 | 13.1 | 65.0% | 34.1% | 5.6% | 3.8% | 5.7 | |
| $2B | 14.4 | 16.4 | 13.7 | 75.1% | 48.2% | 10.7% | 5.1% | 5.1 | |
| $9B | 23.6 | 22.9 | 23.1 | 59.1% | 67.2% | 9.2% | 6.1% | 2.2 | |
| $3B | 23.5 | 16.4 | 15.6 | 36.7% | 51.5% | 9.7% | 5.6% | 4.2 | |
| $39B | 151.1 | 23.2 | 29.5 | -5.9% | 14.2% | 2.1% | 2.5% | 6.0 | |
| $145B | 148.7 | 64.6 | 50.8 | 39.2% | 3.3% | 2.5% | 0.5% | 8.6 | |
| $7B | -27.9 | 16.7 | 54.4 | -33.6% | 8.0% | -4.9% | 0.7% | 6.3 | |
| $14B | 195.6 | 14.7 | 11.9 | 22.5% | 19.3% | 0.8% | 2.3% | 6.5 | |
| $94M | 115.3 | 8.3 | — | — | — | -2.2% | — | — | |
| $3B | -17.1 | 105.4 | 14.6 | — | — | -4.2% | — | 4.6 | |
| Real Estate Median | — | 24.1 | 17.0 | 15.4 | 49.3% | 24.8% | 3.7% | 2.7% | 7.9 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
Deep dive into OHI consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying OHI stock.
Omega Healthcare Investors, Inc.'s current P/E ratio is 23.0x. The historical average is 28.5x. This places it at the 54th percentile of its historical range.
Omega Healthcare Investors, Inc.'s current EV/EBITDA is 16.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 16.4x.
Omega Healthcare Investors, Inc.'s return on equity (ROE) is 11.6%. The historical average is 7.0%.
Based on historical data, Omega Healthcare Investors, Inc. is trading at a P/E of 23.0x. This is at the 54th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Omega Healthcare Investors, Inc.'s current dividend yield is 5.64% with a payout ratio of 132.2%.
Omega Healthcare Investors, Inc. has 44.5% gross margin and 62.6% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Omega Healthcare Investors, Inc.'s Debt/EBITDA ratio is 4.0x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.